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ABSTRACT: Snakebites comprise a serious health problem in several countries due 
to their global incidence, which exceeds 2.5 million per year, and the elevated 
number of victim fatalities. To counteract envenomations, antivenoms have been 
used regularly for more than a century. Apart from side effects including anaphylactic 
reactions, antivenoms are not able to efficiently neutralize local tissue damage, which 
contributes to increasing the severity and morbidity observed in patients. This fact, in 
turn, may be responsible for economic hardship, particularly in rural populations of 
developing countries. In the present work, we evaluated the antiophidian properties 
of 12 Brazilian plant extracts against the hemolytic, coagulant, hemorrhagic and 
proteolytic effects of Lachesis muta venom. Taken together, our data revealed that 
most of these aqueous products were capable of inhibiting those activities at different 
levels, except for Sapindus saponaria extract. In contrast, Stryphnodendron 
barbatiman extract completely neutralized all the analyzed biological activities. Thus, 
we may conclude that Brazilian flora may also be useful against L. muta accidents. 
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INTRODUCTION 
Snake venoms are a complex mixture of components that affect a wide range of 
tissues and organs. We may consider the main active ones to be phospholipases A2 
enzymes, metallo- and serine proteases, phosphodiesterases, myotoxins, lectins, L-
amino acid oxidases, disintegrins and neurotoxins, which are responsible for 
hemorrhage, necrosis, edema, blood clotting, hypotension and neurotoxicity effects 
in victims (1). In Brazil, Bothrops, Crotalus, Lachesis and Micrurus genus are 
responsible for, respectively, 90, 7, 2 and 0.5% of the accidents. But, although the 
accidents caused by Lachesis are rare, the incidence of death (also denominated 
lethality or fatality index) should be considered (2). 
Envenomation by snakes is often treated by parenteral administration of antiophidian 
serum (antivenoms) obtained from hyperimmunized equine serum. This serum 
therapy efficiently neutralizes the systemic toxic effects, thus preventing victim 
fatalities. However, antivenoms present some disadvantages. They can induce 
adverse reactions ranging from mild symptoms to serious ones and they do not 
neutralize the local tissue damage (3). Thus, it is important to search for new venom 
inhibitors, whether synthetic or from a natural source, to complement the traditional 
serum therapy. Hence, the aim of this work was to evaluate the antiophidian 
properties of twelve aqueous plant extracts from Brazilian flora against biological 
effects caused by L. muta snake venom. 
 
MATERIALS AND METHODS 
Venom and Animals 
Lachesis muta snake venom was kindly supplied by the Ezequiel Dias Foundation, 
Belo Horizonte, Minas Gerais state, Brazil, vacuum dried and stored at –20oC until 
experiments. Male Swiss Wistar mice (18-20 g) were obtained from the Center of 
Laboratory Animals (NAL) of the Fluminense Federal University (UFF). 
 
Plant Extracts 
The number of columns, which appears in parenthesis, represents the plant extracts 
in the graphs displayed in the Results section. Leaves, stems and roots of Eclipta 
alba (column 1), Mandevilla velutina (column 2), Mikania glomerata (column 3), 
Jatropha ellyptica (leaves, column 4), Jatropha ellyptica (stems, column 5), Miconia 
fallax (column 6), Miconia albicans (column 7), Miconia sellowiana (column 8), 
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Stryphnodendron barbatiman (column 9), Tibouchina stenocarpa (column 10), 
Casearia sylvestris (column 11) and Sapindus saponaria (column 12) were collected 
from the Biotechnology Unit of the University of Ribeirão Preto (UNAERP), São 
Paulo state, Brazil. A voucher specimen of each plant has been deposited at 
UNAERP and authenticated by Professor Hermógenes de Freitas Leitão Filho of the 
Institute of Biology, State University of Campinas (UNICAMP). Plant extracts were 
prepared according to Maiorano et al. (4) and further dissolved in physiological saline 
solution yielding aqueous extracts. 
 
Inhibition of the Venom 
For inhibition experiments, a fixed amount of L. muta snake venom was mixed with 
varying amounts of plant extracts to obtain two venom:plant ratios (w/w), 1:10 and 
1:20. Then, the mixture was incubated for 30 minutes at room temperature (r.t.), after 
which the biological assays were performed. 
 
Phospholipase A2 (PLA2) Activity 
PLA2 activity was determined by the indirect hemolytic test using human erythrocytes 
and hen’s egg yolk emulsion as substrate (5). One minimum indirect hemolytic dose 
(MIHD) was defined as the amount of L. muta venom (µg/mL) able to produce 70-
80% hemolysis. To verify the inhibitory action of plant extracts, they were 
preincubated with one MIHD and the hemolytic assay was performed. The maximal 
effect (100% hemolysis) was obtained after lysing erythrocytes with distilled water to 
constitute the control. 
 
Clotting Activity 
A normal pool of human plasma from healthy volunteers was mixed with L. muta 
crude venom and clotting experiments were performed in an Organon Teknika BE 
Coagulator 1® (Germany) (6). The amount of venom (µg/mL) that clots plasma in 60 
seconds was denoted as the minimum coagulant dose (MCD). The anticlotting effect 
of plant extracts was determined against one MCD. Plant extracts were used as 
control instead of venom. 
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Hemorrhagic Activity  
Hemorrhagic lesions produced by L. muta venom were quantified by intradermally 
injecting samples into abdominal skin of mice two hours before the animals were 
euthanized according to the UFF Institutional Committee for Ethics in Animal 
Experimentation (7). Then, abdominal skin was removed, stretched and the site of 
injection analyzed. One minimum hemorrhagic dose (MHD) was defined as the 
amount of venom (µg/g) that produced a hemorrhagic halo of 10 mm. Hemorrhagic 
activity was expressed by the means (in mm) of the hemorrhagic halos induced by L. 
muta venom in the absence or presence of plant extracts. Negative control 
experiments were performed by injecting saline, in parallel. 
 
Proteolytic Activity 
Proteolytic activity was determined according to the method of Garcia et al. (8) using 
azocasein as substrate (0.2% w/v, in 20 M Tris-HCl, 8 mM CaCl2, pH 8.8) in the 
presence or absence of plant extracts. One minimum proteolytic dose (MPD) was 
defined as the amount of venom (µg/mL) able to produce a variation of 0.2 at A405 
nm. 
 
Ethics Committee 
The experiments were approved by the UFF Institutional Committee for Ethics in 
Animal Experimentation and are in accordance with the guidelines of the Brazilian 
College for Animal Experimentation (COBEA). 
 
Statistical Analysis 
Results are expressed as means ± SD obtained with the indicated number of animals 
or experiments performed. The statistical significance of differences among 
experimental groups was evaluated using the ANOVA test and p values less than 
0.05 were considered statistically significant. 
 
RESULTS 
A previous study found that L. muta venom presented phospholipase A2 (indirect 
hemolytic activity), hemorrhagic and proteolytic activities and also induced blood 
clotting (9). Herein, we evaluated the ability of different plant extracts to neutralize 
those related biological activities of L. muta crude venom. 
De Paula RC et al. Antiophidian properties of plant extracts against Lachesis muta venom. J Venom Anim Toxins 
incl Trop Dis. 2010;16(2):315 
 
Antihemolytic and Anticlotting Effects 
As shown in Figure 1, plant extracts were able to inhibit the indirect hemolytic (Panel 
A) and clotting (Panel B) activities caused by L. muta venom (12 µg/mL and 15 
µg/mL), but with different potencies. The venom concentrations used above 
represent the MIHD and MCD, respectively. However, the extracts of E. alba (column 
1), M. velutina (column 2), M. fallax (column 6), M. albicans (column 7), S. 
barbatiman (column 9) and T. stenocarpa (column10) inhibited the indirect hemolytic 
activity (100%), in contrast to S. saponaria (column 12) which did not neutralize this 
effect. Meanwhile, E. alba (column 1), M. velutina (column 2), S. barbatiman (column 
9) and T. stenocarpa (column 10) fully inhibited coagulation of L. muta (100%), since 
no clotting was observed throughout ten minutes of observation. However, M. 
glomerata (column 3), J. ellyptica (column 4), J. ellyptica (column 5), M. albicans 
(column 7), M. sellowiana (column 8), S. barbatiman (column 9), T. stenocarpa 
(column 10), C. sylvestris (column 11) and again S. saponaria (column 12) did not 
counteract the clotting effect of L. muta venom. The M. fallax extract (column 6) was 
able to delay clotting fourfold (at 1:20 venom:plant ratio) when compared with venom. 
None of the plant extracts alone produced hemolysis or induced blood clotting (data 
not shown). 
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Figure 1. Inhibition of hemolytic (Panel A) or blood clotting (Panel B) activities of L. 
muta crude venom by plant extracts at 1:10 (white column) or 1:20 (black column) 
venom:plant ratio (w/w). Data are expressed as means ± SD of three individual 
experiments (n = 3). 
* Significance level (p < 0.05) when compared to the white column. 
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Antihemorrhagic and Antiproteolytic Effects 
The effects of aqueous extracts on hemorrhagic (Figure 2A) and proteolytic (Figure 
2B) activities induced by L. muta venom were also analyzed. As observed in Figure 
2A, the extracts of M. glomerata (column 3) and S. saponaria (column 12) did not 
counteract L. muta venom-induced hemorrhage (12.5 µg/g). In contrast, all of the 
other plant extracts (J. ellyptica, column 4; J. ellyptica, column 5; M. fallax, column 6; 
M. sellowiana, column 8; S. barbatiman, column 9 and T. stenocarpa, column 10) did 
neutralize such lesions induced by L. muta venom and produced inhibition of around 
100 % (Figure 2A).  
It is worth noting that S. barbatiman extract (column 9) produced 100% inhibition of a 
three-fold MHD (30 µg/g) of L. muta (data not shown). In parallel, plant extracts also 
inhibited one MPD of L. muta venom (10 µg/mL) with different potencies (Figure 2B). 
As shown, the extracts of M. velutina (column 2) and M. glomerata (column 3) 
presented the lowest inhibitory effect (60 and 65 % for 1:10 venom:plant ratio; 85% 
and 65% for 1:20) while S. sapindus (column 12) was not capable of inhibiting this 
phenomenon. The other plant extracts – J. ellyptica (column 4), J. ellyptica (column 
5), M. fallax (column 6), M. albicans (column 7), M. sellowiana (column 8), S. 
barbatiman (column 9) and T. stenocarpa (column 10) – inhibited 100% of L. muta 
proteolytic activity (10 µg/mL) according to both venom:plant ratios evaluated (Figure 
2B). Again, plant extracts or saline alone did not produce hemorrhagic lesions or 
interfere in the proteolytic assay (data not shown). 
 
De Paula RC et al. Antiophidian properties of plant extracts against Lachesis muta venom. J Venom Anim Toxins 
incl Trop Dis. 2010;16(2):318 
 
1 2 3 4 5 6 7 8 9 10 11 12
0
20
40
60
80
100 *
*
*
A
 
 
H
em
or
rh
ag
e 
in
hi
bi
tio
n
Plant extracts
 
1 2 3 4 5 6 7 8 9 10 11 12
0
20
40
60
80
100
*
*
B
 
P
ro
te
ol
ys
is
 in
hi
bi
tio
n
Plant extracts
 
Figure 2. Inhibition of L. muta venom-induced hemorrhagic (Panel A) or proteolytic 
(Panel B) activities by plant extracts at 1:10 (white column) or 1:20 (black column) 
venom:plant ratio (w/w). Data are expressed as means ± SD of four individual 
experiments (n = 4).  
* Significance level (p < 0.05) when compared to the white column. 
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Inhibitory Profile of Plant Extracts 
Furthermore, we compared the inhibitory profile of plant extracts according to their 
indirect hemolytic (hemolysis), clotting, hemorrhagic and proteolytic biological 
activities (Table 1). As shown in Table 1, none of these activities was affected by S. 
saponaria. However, M. glomerata and J. ellyptica (stems) extracts were not able to 
completely inhibit any activity; but M. velutina, J.ellyptica (leaves) or C. sylvestris 
extracts fully inhibited at least one activity (clotting, proteolytic and proteolytic, 
respectively). On the other hand, the extracts of M. fallax (hemolysis and 
hemorrhagic), M. albicans (hemorrhagic and proteolytic), M. sellowiana (hemolysis 
and proteolytic), S. barbatiman (hemolysis, hemorrhagic and proteolytic) and T. 
stenocarpa (hemolysis, hemorrhagic and proteolytic), inhibited 100% of at least two 
of those activities. Also, it is worth highlighting that only the S. barbatiman extract 
fully abolished all of the activities assessed in this work (Table 1). 
 
Table 1. Inhibitory percentage of plant extracts against L. muta snake venom’s 
biological activities 
Extracts Hemolysisa Hemorrhagicb Clottingc Proteolyticd
E. alba (roots) 100 75 100 100 
M. velutina (roots) 86 80 100 60 
M. glomerata (roots) 21 0 15 64 
J. ellyptica (leaves) 44 0 20 100 
J. ellyptica (stems) 74 94 18 91 
M. fallax (stems)  100 100 33.3 100 
M. albicans (stems) 75 100 0 100 
M. sellowiana (n.d.)  100 71 0 100 
S. barbatiman (roots) 84 100 100 98 
T. stenocarpa (roots) 100 100 61 100 
C. sylvestris (roots) 10 61 18 100 
S. saponaria (roots) 0 0 0 0 
Plant extracts were preincubated with L. muta crude venom at 1:10 ratio (venom:plant, w/w) and then 
assayed for these activities. The values above are expressed as inhibition percentage (%) of the 
venom amount able to produce: 70-80% hemolysis (MIHD)a; hemorrhagic halo of 10 mm (MHD)b; clot 
plasma in 60 seconds (MCD)c; produce a variation of 0.2 nm at 420 nm (MPD)d. 
n.d.: not determined. 
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DISCUSSION 
Given the high incidence of accidents caused by Bothrops and Crotalus species, 
data from the literature have focused much attention on them (10). But, although the 
accidents caused by L. muta snake venom are rare, they also represent a medical 
problem in Brazil, especially because of the high lethality index (1.0%) when 
compared to approximately 0.3% for the Bothrops genus (2).  
Envenomation by L. muta promotes a wide range of symptoms including nociception, 
edema and muscle necrosis, as well as neurotoxic, hemorrhagic, hemolytic and 
blood clotting disorders. These effects are related to the presence of phospholipase 
A2 enzymes, serino- and metalloproteases, L-amino acid oxidases, nucleotidases 
and others. The pathophysiological alterations may cause victims to die. To 
counteract those systemic and local effects of venoms, an antiserum is used as 
treatment.  
According to the Brazilian Health Ministry and World Health Organization (11) 
guidelines, the antiophidic serum is produced by the following three public institutes 
in Brazil: the Butantan Institute in São Paulo city, São Paulo state; Ezequiel Dias 
Foundation in Belo Horizonte city, Minas Gerais state; and the Vital Brasil Institute, in 
Niterói city, Rio de Janeiro state; and then distributed free of charge to hospitals. As 
far as we know, this treatment is not efficient enough to neutralize local effects, thus 
contributing to high morbidity indexes observed in Brazil (2, 12-15). 
Indeed, antisera possess some disadvantages such as side effects in victims, poor 
availability in distant areas, delays in administration, need for refrigeration, high cost 
and low efficacy (3, 10). Furthermore, snake venoms have both inter- and 
intraspecific variation in composition that, in turn, may affect antivenom neutralization 
ability (16). Because of these factors, alternative treatments for snakebite are under 
investigation and plant extracts constitute a rich source of molecules with several 
pharmacological properties (4, 17, 18).  
In several countries, plants have been used by indigenous groups and in folk 
medicine against snake bite envenomation. However, in most of the cases, scientific 
validation of their antiophidian properties is needed. As far as we know, there are 
many examples of medicinal plants in folk medicine and it is believed that 80% of the 
world population uses plants as the first-line treatment in cases of envenomation 
(18). Although the action mechanism remains unknown, several reports have shown 
that plant-derived compounds including rosmarinic acid, quercetin, aristolochic acid 
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pterocarpans and terpenoids and crude extracts are able to neutralize toxic snake 
venom effects (17, 19-23). 
In the present experiment we demonstrated for the first time the ability of different 
aqueous plant extracts to neutralize biological effects of L. muta snake venom, due 
to the scarcity of data on the use of plants to neutralize its venom. All of the plant 
extracts tested in this work inhibited at least one biological activity, except for S. 
saponaria that failed to neutralize any activity. The biological activities evaluated 
herein are relevant to envenomation symptoms such as necrosis, hemolysis, 
hemorrhage, inflammation, edema and pain, which obviously may contribute to victim 
fatalities. Therefore, vegetal extracts appears as an alternative treatment against 
local damage to complement the serum therapy or may be useful as prototypes for 
designing new antiophidian molecules to improve the current treatment used for L. 
muta bites. 
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